<?xml version="1.0" ?>
<proxyVoteTable xmlns="http://www.sec.gov/edgar/document/npxproxy/informationtable">
  <proxyTable>
    <issuerName>Carlyle AlpInvest Private Markets SICAV UCI Part II</issuerName>
    <isin>LU2827810776</isin>
    <meetingDate>05/22/2026</meetingDate>
    <voteDescription>1. Amendment to the definition of AIFMD in article 1 &quot;Name and Legal Form&quot; of the articles of association of the Fund (the Articles)</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>OTHER</categoryType>
      </voteCategory>
    </voteCategories>
    <otherVoteDescription>Other Voting Matters</otherVoteDescription>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>10403981.43</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>0</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
    <voteOtherInfo>The Articles needed to be updated to comply with new AIFMD 2 regulatory requirements. All amendments were purely procedural for the purpose of compliance with technical legal requirements, and did not change Fund terms or otherwise substantively modify the Articles.</voteOtherInfo>
  </proxyTable>
  <proxyTable>
    <issuerName>Carlyle AlpInvest Private Markets SICAV UCI Part II</issuerName>
    <isin>LU2827810776</isin>
    <meetingDate>05/22/2026</meetingDate>
    <voteDescription>2. Amendment of sub-article 7.3 of article 7 &quot;Shares: Eligibility and Subscriptions&quot; of the Articles to include &quot;suspend&quot;;</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>OTHER</categoryType>
      </voteCategory>
    </voteCategories>
    <otherVoteDescription>Other Voting Matters</otherVoteDescription>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>10403981.43</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>0</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
    <voteOtherInfo>The Articles needed to be updated to comply with new AIFMD 2 regulatory requirements. All amendments were purely procedural for the purpose of compliance with technical legal requirements, and did not change Fund terms or otherwise substantively modify the Articles.</voteOtherInfo>
  </proxyTable>
  <proxyTable>
    <issuerName>Carlyle AlpInvest Private Markets SICAV UCI Part II</issuerName>
    <isin>LU2827810776</isin>
    <meetingDate>05/22/2026</meetingDate>
    <voteDescription>3. Amendment of sub-article 19.8 of article 19 &quot;Net Asset Value: Calculation and Suspension&quot; of the Articles in order to correct a clerical error;</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>OTHER</categoryType>
      </voteCategory>
    </voteCategories>
    <otherVoteDescription>Other Voting Matters</otherVoteDescription>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>10403981.43</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>0</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
    <voteOtherInfo>The Articles needed to be updated to comply with new AIFMD 2 regulatory requirements. All amendments were purely procedural for the purpose of compliance with technical legal requirements, and did not change Fund terms or otherwise substantively modify the Articles.</voteOtherInfo>
  </proxyTable>
  <proxyTable>
    <issuerName>Carlyle AlpInvest Private Markets SICAV UCI Part II</issuerName>
    <isin>LU2827810776</isin>
    <meetingDate>05/22/2026</meetingDate>
    <voteDescription>4. Amendment of sub-article 19.9 of article 19 &quot;Net Asset Value: Calculation and Suspension&quot; of the Articles;</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>OTHER</categoryType>
      </voteCategory>
    </voteCategories>
    <otherVoteDescription>Other Voting Matters</otherVoteDescription>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>10403981.43</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>0</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
    <voteOtherInfo>The Articles needed to be updated to comply with new AIFMD 2 regulatory requirements. All amendments were purely procedural for the purpose of compliance with technical legal requirements, and did not change Fund terms or otherwise substantively modify the Articles.</voteOtherInfo>
  </proxyTable>
  <proxyTable>
    <issuerName>Carlyle AlpInvest Private Markets SICAV UCI Part II</issuerName>
    <isin>LU2827810776</isin>
    <meetingDate>05/22/2026</meetingDate>
    <voteDescription>5. Amendment of sub-article 20.1 of article 20 &quot;Redemption of Shares&quot; of the Articles and introduction of a new sub-article 20.2;</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>OTHER</categoryType>
      </voteCategory>
    </voteCategories>
    <otherVoteDescription>Other Voting Matters</otherVoteDescription>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>10403981.43</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>0</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
    <voteOtherInfo>The Articles needed to be updated to comply with new AIFMD 2 regulatory requirements. All amendments were purely procedural for the purpose of compliance with technical legal requirements, and did not change Fund terms or otherwise substantively modify the Articles.</voteOtherInfo>
  </proxyTable>
  <proxyTable>
    <issuerName>Carlyle AlpInvest Private Markets SICAV UCI Part II</issuerName>
    <isin>LU2827810776</isin>
    <meetingDate>05/22/2026</meetingDate>
    <voteDescription>6. Amendment of sub-article 31.1 of article 31 &quot;&quot;Liquidation, merger, split of sub-funds and classes&quot;&quot; of the Articles in order to correct a clerical error;</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>OTHER</categoryType>
      </voteCategory>
    </voteCategories>
    <otherVoteDescription>Other Voting Matters</otherVoteDescription>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>10403981.43</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>0</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
    <voteOtherInfo>The Articles needed to be updated to comply with new AIFMD 2 regulatory requirements. All amendments were purely procedural for the purpose of compliance with technical legal requirements, and did not change Fund terms or otherwise substantively modify the Articles.</voteOtherInfo>
  </proxyTable>
  <proxyTable>
    <issuerName>Carlyle AlpInvest Private Markets SICAV UCI Part II</issuerName>
    <isin>LU2827810776</isin>
    <meetingDate>05/22/2026</meetingDate>
    <voteDescription>7. Amendment to the definition of AIFMD in article 35 &quot;Definitions and Interpretation&quot; of the Articles;</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>OTHER</categoryType>
      </voteCategory>
    </voteCategories>
    <otherVoteDescription>Other Voting Matters</otherVoteDescription>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>10403981.43</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>0</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
    <voteOtherInfo>The Articles needed to be updated to comply with new AIFMD 2 regulatory requirements. All amendments were purely procedural for the purpose of compliance with technical legal requirements, and did not change Fund terms or otherwise substantively modify the Articles.</voteOtherInfo>
  </proxyTable>
  <proxyTable>
    <issuerName>Carlyle AlpInvest Private Markets SICAV UCI Part II</issuerName>
    <isin>LU2827810776</isin>
    <meetingDate>05/22/2026</meetingDate>
    <voteDescription>8. Subsequent amendment and complete restatement of the Articles with effect as of the date of the extraordinary general meeting</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>OTHER</categoryType>
      </voteCategory>
    </voteCategories>
    <otherVoteDescription>Other Voting Matters</otherVoteDescription>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>10403981.43</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>For</howVoted>
        <sharesVoted>0</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
    <voteOtherInfo>The Articles needed to be updated to comply with new AIFMD 2 regulatory requirements. All amendments were purely procedural for the purpose of compliance with technical legal requirements, and did not change Fund terms or otherwise substantively modify the Articles.</voteOtherInfo>
  </proxyTable>
</proxyVoteTable>
